SCHEMBL2255733

SCHEMBL2255733

O=C(Cc1cc(-c2ccc(F)cc2)ccc1C(=O)O)Nc1ccc2cccc(O)c2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARA Q07869 1/20 0.43
▸ STING1 Q86WV6 1/20 0.43
▸ KMT2A Q03164 7/20 0.42
▸ MEN1 O00255 6/20 0.42
▸ DCLRE1B Q9H816 1/20 0.41
▸ KDM4E B2RXH2 3/20 0.41
▸ HPGD P15428 2/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ TRPV1 Q8NER1 1/20 0.41
▸ FDPS P14324 1/20 0.41
▸ LMNA P02545 3/20 0.40
▸ PTGER4 P35408 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ XDH P47989 1/20 0.39
▸ SLC22A12 Q96S37 1/20 0.39
▸ POLB P06746 2/20 0.39
▸ GRIN2D O15399 1/20 0.39
▸ GRIN2A Q12879 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2255199 0.83 AKR1C3 (0.47) PPARASTING1KMT2AMEN1KDM4E
SCHEMBL2255077 0.80 ACLY (0.52) PPARASTING1KMT2AMEN1KDM4E
SCHEMBL2257615 0.79 SOX18 (0.46) PPARASTING1DCLRE1BGRIN2DGRIN2A
SCHEMBL2254380 0.77 DCLRE1B (0.43) PPARASTING1DCLRE1BGRIN2DGRIN2A
SCHEMBL2253800 0.75 ACLY (0.50) PPARASTING1HPGDALDH1A1TRPV1
SCHEMBL2254967 0.74 HSD17B1 (0.48) PPARASTING1KMT2AMEN1KDM4E
SCHEMBL2256138 0.74 HCAR2 (0.59) TRPV1
SCHEMBL2257660 0.74 ACLY (0.49) KMT2AMEN1GRIN2DGRIN2AGRIN2B
SCHEMBL2254452 0.72 MTNR1A (0.47) KMT2AMEN1DCLRE1BTRPV1FDPS
SCHEMBL11351242 0.71 CTDSP1 (0.56) KMT2AMEN1KDM4EHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1904047-B1 APOPTOSIS PROMOTERS ABBOTT LAB (US) 2013-01-02 — — EP disclosed
US-7989656-B2 Biaryl carboxylic acid apoptosis promoters ABBOTT LABORATORIES (US) 2011-08-02 — — US disclosed
US-20100234456-A1 APOPTOSIS PROMOTERS ABBOTT LABORATORIES (US) 2010-09-16 — — US disclosed
US-7750004-B2 Apoptosis promoters ABBOTT LABORATORIES (US) 2010-07-06 — — US disclosed
US-20070135392-A1 Apoptosis promoters ABBVIE INC. 2007-06-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234456-A1 APOPTOSIS PROMOTERS MCL1, BAX, BCL2 PPARA 2676/4885STING1 657/4885KMT2A 2158/4885
US-20070135392-A1 Apoptosis promoters MCL1, BAX, BCL2 PPARA 2676/4885STING1 657/4885KMT2A 2158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback